Ovid Therapeutics (OVID) Stock Chart & Stock Price History $0.51 +0.00 (+0.66%) Closing price 04:00 PM EasternExtended Trading$0.50 -0.01 (-2.51%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ovid Therapeutics Stock Price Performance The Ovid Therapeutics (OVID) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 43.73%, with a year-to-date return of -44.85%. In the past month, the stock has increased 19.74%, reflecting recent market activity. As of the latest close, Ovid Therapeutics traded at $0.51 with a market cap of $36.37 million and volume of 429,701 shares. Five years ago, the stock traded at $7.19, representing a 92.84% decrease over that period. At the time, it had a market cap of $384.35 million and a volume of 574,372 shares. Receive OVID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.98%1 Month Performance+19.74%3 Month Performance+75.14%Year-To-Date Performance-44.85%1 Year Performance-43.73%5 Year Performance-92.84% OVID Stock Chart for Friday, August, 8, 2025 OVID Chart by TradingView Ovid Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$0.51$0.51+0.66%$0.54$0.50381,631 shs$36.62 million08/07/2025$0.51$0.51+0.25%$0.52$0.50429,701 shs$36.37 million08/06/2025$0.50$0.51+2.80%$0.51$0.48337,146 shs$36.28 million08/05/2025$0.50$0.50-0.04%$0.51$0.48603,099 shs$35.29 million08/04/2025$0.50$0.50-0.70%$0.51$0.48574,117 shs$35.31 million08/01/2025$0.50$0.50$0.51$0.48535,545 shs$35.56 million07/31/2025$0.50$0.50$0.52$0.48800,863 shs$35.56 million07/30/2025$0.54$0.50-7.46%$0.55$0.491.16 million shs$35.56 million07/29/2025$0.53$0.54+2.43%$0.58$0.521.09 million shs$38.42 million07/28/2025$0.62$0.53-14.71%$0.63$0.521.57 million shs$37.51 million Get the Latest News and Ratings for OVID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$0.69$0.62-10.75%$0.70$0.611.08 million shs$43.98 million07/24/2025$0.70$0.69-1.00%$0.73$0.602.14 million shs$49.28 million07/23/2025$0.67$0.70+4.65%$0.73$0.681.94 million shs$49.78 million07/22/2025$0.61$0.67+10.49%$0.67$0.591.78 million shs$47.57 million07/21/2025$0.55$0.61+10.07%$0.63$0.562.66 million shs$43.05 million07/18/2025$0.48$0.55+14.75%$0.57$0.483.44 million shs$39.11 million07/17/2025$0.39$0.48+22.90%$0.61$0.4124.44 million shs$34.08 million07/16/2025$0.37$0.39+5.98%$0.40$0.36495,126 shs$27.73 million07/15/2025$0.40$0.37-7.28%$0.41$0.36805,184 shs$26.17 million07/14/2025$0.41$0.40-2.00%$0.41$0.39443,469 shs$28.22 million07/11/2025$0.42$0.41-3.34%$0.44$0.39584,241 shs$28.80 million07/10/2025$0.44$0.42-4.21%$0.44$0.41672,421 shs$29.80 million07/09/2025$0.43$0.44+1.72%$0.46$0.401.54 million shs$31.10 million07/08/2025$0.37$0.43+14.97%$0.45$0.391.70 million shs$30.58 million07/07/2025$0.34$0.37+8.72%$0.39$0.331.62 million shs$26.60 million Related Companies NVCT Stock Price Chart GNLX Stock Price Chart CGEN Stock Price Chart KRRO Stock Price Chart SPRO Stock Price Chart BHST Stock Price Chart FATE Stock Price Chart MCRB Stock Price Chart IMRX Stock Price Chart PLX Stock Price Chart Receive OVID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OVID) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Ovid Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.